Accelsiors CRO & Consultancy Services

Let our experienced team guide or assist you in making a fast and effective drug development.

Completion of Phase III Trial in Oncology
Accelsiors CRO announce successful completion of a Phase III study in oncology.
New Phase II Trial in Hepatitis C
Accelsiors CRO announce start of set-up and regulatory procedures for the Phase II Clinical Trial in Hepatitis C.

Accelsiors is a midsized, full-service, European CRO. We have designed and conducted several Phase I-II-III trials with involvement of complex clinical, PK/PD, immunological, and imaging assessment. Accelsiors is a synonym for acceleration, excellence and achievements in clinical drug development.